Page 14 - Anjali Singh

Entry-level bikes vroom ahead on rural sentiment, rate cut push

Sub-125cc segment is 29% of motorcycle sales, 18% of two-wheeler volumes

Inventories of rare earth magnets may run dry by mid-July, says Icra

ICRA warns that rare-earth magnet inventories for EV motors may run dry by mid-July as China tightens export rules, leaving Indian auto makers facing serious supply disruption

HDFC Bank-LKMM Trust row escalates amid claims over loan irregularities

As LKMM Trust questions the existence of a loan and cites missing documentation, HDFC Bank calls the allegations false and prepares for legal action to protect its interests

Hospitals raise cybersecurity spend amid rising attacks, AI adoption

As cyber threats grow more advanced, hospitals are raising cybersecurity budgets, adopting AI-driven tools and preparing for stricter healthcare data regulations

Auto sector faces slowdown due to rare earth magnet shortage: Crisil

Automakers may face production delays from July as rare earth magnet supply tightens following China's export curbs, with Crisil warning of disruptions in EV and hybrid output

TaMo eyes 40% CV, 16% PV market share; EV biz hits Ebitda breakeven

Tata Motors targets 40% share in CVs and 16% in PVs by FY27, plans major EV investments and demerger of vehicle businesses by end-2025

Two-wheeler sales may cross pre-Covid levels in FY26 on export rebound

CareEdge sees 8-9% growth in FY26 as domestic recovery, exports, EV adoption, and affordability drive two-wheeler demand beyond pre-Covid highs

HDFC Bank to pursue legal remedies against Mehta family of Lilavati Trust

The bank rejected the "malicious and baseless allegations" levelled against HDFC Bank's MD and CEO Sashidhar Jagdishan

Dr Reddy's, Alvotech to co-develop biosimilar of cancer drug Keytruda

The partnership marks a strategic boost to Dr Reddy's oncology portfolio and expands Alvotech's biosimilar pipeline as Keytruda patents near expiry

Classic Legends targets FY26 profitability with new launches, expansion

Classic Legends is betting big on product innovation, network expansion, and exports to achieve profit before tax (PBT)-level profitability by FY26, said a senior company executive

Zydus enters biologics CDMO market with $125 million acquisitions

Zydus Lifesciences will acquire two US biologics manufacturing facilities from Agenus for up to $125 million, gaining immediate manufacturing capabilities and expanding its global presence

Two-wheeler majors bounce back with strong double-digit growth in May

Analysts estimate a 4 to 7 per cent rise in FY26, driven by product innovation, supportive policy frameworks, and increasing mobility needs in emerging markets

Glenmark's cancer drug shows strong results in early trial for Myeloma

In the dose-escalation stage of the trial, 35 patients were treated, most of whom had received a median of six prior therapies

Rare earth supply pinch puts India's EV makers on a six-week clock

China controls 92 per cent of global REM magnet production, with other players like Japan (7 per cent) and Vietnam (1 per cent) contributing marginally

Bajaj Auto Q4 results: Net profit falls 10.4% to ₹1,802 cr; revenue up 8%

The decline in the net profit was attributed to subdued performance in the domestic motorcycle market

Schaeffler to invest €500 million in India, opens fifth plant in Tamil Nadu

German firm Schaeffler will invest €500 million in India over five years to grow EV, rail, and renewable businesses and deepen localisation amid global shifts

Aurobindo Pharma Q4 net dips 0.5%, revenue up 10.5% to Rs 8,382 cr

US and Europe markets drive growth as company posts flat profit for Q4 FY25; files 9 ANDAs and launches 5 new products during the quarter

Lupin signs licensing deal with SteinCares for ranibizumab in LatAm

Lupin will manufacture biosimilar ranibizumab while SteinCares handles registration and marketing in Latin America, excluding Mexico and Argentina

Indian tyre companies draw up road map to steer through tariff jitters

Despite low US exposure, Indian tyre makers are crafting mitigation strategies to address looming tariff threats and persistent margin pressures due to high input costs

Private hospitals step up Covid readiness amid mild case uptick in India

Despite a mild rise in cases and no fresh central advisory, private hospitals across India are enhancing Covid protocols and issuing cautionary measures to safeguard high-risk groups